A Win For Stealth BioTherapeutics Corp
Fri 29 Nov 19 at 05:30 PM
Stealth BioTherapeutics Corp (MITO:NASDAQ) shot up at $11.53, representing a gain of 35.6%. On Thu 28 Nov 19, MITO:NASDAQ hit a New 2-Week Intraday High of $8.71. The stock appeared on our News Catalysts scanner on Tue 19 Nov 19 at 05:30 PM in the 'MISCELLANEOUS' category. From Thu 07 Nov 19, the stock recorded 85.71% Up Days and 66.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Stealth BioTherapeutics Corp (MITO:NASDAQ)
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.
Top 10 Gainers:
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 64.66%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 58.17%
- Pintec Technology Holdings Limited (PT:NASDAQ), 48.89%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 37.74%
- Stealth BioTherapeutics Corp (MITO:NASDAQ), 35.65%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 34.33%
- Sequans Communications S.A. (SQNS:NYSE), 33.19%
- SORL Auto Parts, Inc. (SORL:NASDAQ), 30%
- TransAtlantic Petroleum Ltd. (TAT:NYSEMKT), 25.49%
- Novavax, Inc. (NVAX:NASDAQ), 23.1%